Capricor Therapeutics Reports Q2 2026 Financial Results

What Happened
On August 13, 2026, Capricor Therapeutics, Inc. (NASDAQ: CAPR) announced its financial results for the quarter ended June 30, 2026 and furnished a press release as Exhibit 99.1 to a Form 8-K (Item 2.02). The filing was signed by CEO Linda Marbán, Ph.D., and includes the company’s quarterly results and a corporate update in the released communication.

Key Details

• Filing date: August 13, 2026 (Form 8-K) — Item 2.02: Results of Operations and Financial Condition.
• Period covered: Quarter ended June 30, 2026 (Q2 2026 quarterly results).
• Exhibit furnished: Exhibit 99.1 — Press Release titled “Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update” (dated Aug 13, 2026).
• Administrative: Cover page interactive XBRL file included (Exhibit 104); filing signed by CEO Linda Marbán, Ph.D.

Why It Matters
This 8-K publicly communicates Capricor’s official quarterly results and any corporate updates that can affect investor views on revenue, cash position, program progress, or guidance. Retail investors should review the included press release (Exhibit 99.1) and the company’s subsequent filings for the specific financial figures and operational details to assess impacts on valuation and near-term outlook.